Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Good morning. The news coming out of D.C. never stops. We get into all of it below.

Trump reportedly discussing crackdown on Chinese drugs

The Trump administration is considering implementing severe restrictions on drugs from China, including Chinese-invented experimental treatments, The New York Times reported this morning.

The Times obtained a draft of an executive order that includes a policy that would impose heavier scrutiny on deals in which U.S. drugmakers buy rights to candidates from Chinese companies. American companies have increasingly looked to China to license treatments for cancer and obesity.

The draft also includes a policy that would dis

See Full Page